Posner; Gary
Patent Applications and Registrations
Patent applications and USPTO patent grants for Posner; Gary.The latest application filed is for "treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents".
- Posner; Gary - Baltimore MD
| Patent | Date |
|---|---|
| Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents Grant 9,918,972 - Civin , et al. March 20, 2 | 2018-03-20 |
| Treatment Of Leukemia With Artemisinin Derivatives And Combinations With Other Antineoplastic Agents App 20160175331 - CIVIN; Curt ; et al. | 2016-06-23 |
| Anti-cytomegalovirus activity of artemisinin-derived dimers Grant 8,883,765 - Arav-Boger , et al. November 11, 2 | 2014-11-11 |
| Anti-cytomegalovirus Activity Of Artemisinin-derived Dimers App 20130109654 - Arav-Boger; Ravit ; et al. | 2013-05-02 |
| 24-sulfoximine vitamin D.sub.3 compounds Grant 7,973,024 - Posner , et al. July 5, 2 | 2011-07-05 |
| Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin D3 Grant 6,982,258 - Posner , et al. January 3, 2 | 2006-01-03 |
| Low-calcemic oxime analogs of 1alpha,25-dihydroxy vitamin D3 App 20030171342 - Posner, Gary ; et al. | 2003-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 